DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. Its platform technologies include the SABER Delivery System, a depot injectable useful for proteins, peptides, and small molecule delivery; the ORADUR, an oral sustained release technology with various potential abuse deterrent properties; the TRANSDUR transdermal patch technology; the DURIN Biodegradable Implant, a drug-loaded implant system; and the MICRODUR Biodegradable Microparticulates, a microspheres injectable system. The company primarily develops pharmaceutical systems to treat chronic and episodic diseases and...